D-1704-2019 Class II Terminated

Recalled by RXQ Compounding LLC — Athens, OH

FDA drug recall D-1704-2019 was initiated by RXQ Compounding LLC on Jun 19, 2019 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated Sep 16, 2022).

Recall details

Product Type
Drugs
Report Date
Aug 14, 2019
Initiation Date
Jun 19, 2019
Termination Date
Sep 16, 2022
Voluntary/Mandated
Voluntary: Firm initiated

Product description

SODIUM BICARBONATE 8.4% (1 MEQ/ML) INJ SOLN (PFV), 50 ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0957-50

Reason for recall

Lack of Assurance of Sterility

Distribution pattern

Nationwide USA

Code information

All lots within expiry

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1704-2019
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for RXQ Compounding LLC? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-1704-2019. Report a data issue: hello@regdatalab.com.